Tibet AIM Pharm. Inc. (SHE:002826)

Tibet AIM Pharm. Revenue

Tibet AIM Pharm. had revenue of 177.54M CNY in the quarter ending September 30, 2025, with 10.37% growth. This brings the company's revenue in the last twelve months to 628.02M, down -2.11% year-over-year. In the year 2024, Tibet AIM Pharm. had annual revenue of 651.88M, down -2.27%.

• Revenue (ttm): 628.02M
• Revenue Growth: -2.11%
• P/S Ratio: 6.40
• Revenue / Employee: 1.56M
• Employees: 403
• Market Cap: 4.02B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	651.88M	-15.16M	-2.27%
Dec 31, 2023	667.04M	-189.70M	-22.14%
Jan 1, 2023	856.73M	131.28M	18.10%
Jan 1, 2022	725.46M	122.84M	20.38%
Dec 31, 2020	602.62M	49.36M	8.92%